Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Langdon

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|October 15, 1998
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoS P Langdon, G J Rabiasz, A A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft modelS P Langdon, A J Crew, A A Ritchie, et al.
British Journal of Cancer|June 9, 1999
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell linesK E Wilson, J M Bartlett, E P Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological featuresB J Simpson, A D Ramage, M J Hulme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing miceJ Cummings, S P Langdon, A A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenograftsS P Langdon, A A Ritchie, M Muir, et al.
Journal of Medicinal Chemistry|June 1, 1986
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamideE N Gate, M D Threadgill, M F Stevens, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|October 15, 1998
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoS P Langdon, G J Rabiasz, A A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft modelS P Langdon, A J Crew, A A Ritchie, et al.
British Journal of Cancer|June 9, 1999
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell linesK E Wilson, J M Bartlett, E P Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological featuresB J Simpson, A D Ramage, M J Hulme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing miceJ Cummings, S P Langdon, A A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenograftsS P Langdon, A A Ritchie, M Muir, et al.
Journal of Medicinal Chemistry|June 1, 1986
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamideE N Gate, M D Threadgill, M F Stevens, et al.
Pageof 8